MA39823A - Dérivés de pyridine macrocyclique - Google Patents
Dérivés de pyridine macrocycliqueInfo
- Publication number
- MA39823A MA39823A MA039823A MA39823A MA39823A MA 39823 A MA39823 A MA 39823A MA 039823 A MA039823 A MA 039823A MA 39823 A MA39823 A MA 39823A MA 39823 A MA39823 A MA 39823A
- Authority
- MA
- Morocco
- Prior art keywords
- pyridine derivatives
- macrocyclic
- macrocyclic pyridine
- derivatives
- pyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14163442 | 2014-04-03 | ||
| EP14183823 | 2014-09-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA39823A true MA39823A (fr) | 2018-01-09 |
Family
ID=52781118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA039823A MA39823A (fr) | 2014-04-03 | 2015-04-01 | Dérivés de pyridine macrocyclique |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20170022201A1 (fr) |
| EP (1) | EP3126365B1 (fr) |
| JP (1) | JP6420362B2 (fr) |
| KR (1) | KR102390274B1 (fr) |
| CN (1) | CN106132964B (fr) |
| AU (1) | AU2015239100B2 (fr) |
| BR (1) | BR112016022700B1 (fr) |
| CA (1) | CA2942751C (fr) |
| CL (1) | CL2016002495A1 (fr) |
| EA (1) | EA029758B1 (fr) |
| ES (1) | ES2665797T3 (fr) |
| IL (1) | IL248001B (fr) |
| MA (1) | MA39823A (fr) |
| MX (1) | MX369799B (fr) |
| MY (1) | MY185500A (fr) |
| NZ (1) | NZ725406A (fr) |
| PE (1) | PE20161365A1 (fr) |
| PH (1) | PH12016501962A1 (fr) |
| SG (1) | SG11201608241UA (fr) |
| UA (1) | UA118120C2 (fr) |
| WO (1) | WO2015150557A1 (fr) |
| ZA (1) | ZA201606768B (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2998885C (fr) | 2015-09-24 | 2020-09-01 | Cyclenium Pharma Inc. | Bibliotheques de composes macrocycliques contenant heteroaryle et procedes pour leur fabrication et leur utilisation |
| PL3416945T3 (pl) | 2016-02-19 | 2020-12-28 | Sprint Bioscience Ab | Związki 6-arylo-4-(morfolin-4-ylo)-1h-pirydyn-2-onu przydatne w leczeniu nowotworu i cukrzycy |
| PT3416957T (pt) | 2016-02-19 | 2020-09-25 | Sprint Bioscience Ab | Compostos 6-heterociclil-4-morfolin-4-ilpiridin-2-ona úteis para o tratamento do cancro e da diabetes |
| US11046685B2 (en) | 2017-02-28 | 2021-06-29 | Morphic Therapeutic, Inc. | Inhibitors of (α-v)(β-6) integrin |
| EP4159727B1 (fr) | 2017-02-28 | 2026-04-08 | Morphic Therapeutic, Inc. | Inhibiteurs de l'intégrine (alpha-v)(bêta-6) |
| EP3601253B1 (fr) | 2017-03-28 | 2021-09-15 | Bayer Aktiengesellschaft | Nouveaux composés macrocycliques inhibiteurs de ptefb |
| CA3057891A1 (fr) | 2017-03-28 | 2018-10-04 | Bayer Aktiengesellschaft | Nouveaux composes macrocycliques inhibiteurs de ptefb |
| WO2018232506A1 (fr) * | 2017-06-22 | 2018-12-27 | Cyclenium Pharma Inc. | Bibliothèques de composés macrocycliques contenant de la pyridine et leurs procédés de préparation et d'utilisation |
| HRP20220497T1 (hr) | 2017-08-23 | 2022-05-27 | Sprint Bioscience Ab | Spoj morfolinilpiridona |
| PL3672948T3 (pl) | 2017-08-23 | 2022-12-05 | Sprint Bioscience Ab | Związki pirydynoamino-pirydonu i pirymidynoamino-pirydonu |
| IL302355A (en) | 2017-08-23 | 2023-06-01 | Sprint Bioscience Ab | Azaindolylpyridone and diazaindolylpyridone compounds |
| IL302356A (en) | 2017-08-23 | 2023-06-01 | Sprint Bioscience Ab | Pyridylpyridone compounds |
| PT3844162T (pt) | 2018-08-29 | 2025-03-28 | Morphic Therapeutic Inc | Inibidores da integrina alfa v beta6 |
| AU2019327475B2 (en) | 2018-08-29 | 2025-06-05 | Morphic Therapeutic, Inc. | INHIBITING αV β6 INTEGRIN |
| WO2020047208A1 (fr) | 2018-08-29 | 2020-03-05 | Morphic Therapeutic, Inc. | Inhibiteurs de l'intégrine (alpha-v)(bêta-6) |
| JP2022545407A (ja) * | 2019-08-16 | 2022-10-27 | インフレイゾーム リミテッド | Nlrp3阻害剤として有用な大環状スルホニルアミド誘導体 |
| CN113845521B (zh) * | 2021-08-31 | 2024-06-18 | 中原工学院 | 水相中光催化一锅法合成咪唑并含氮杂环肼类衍生物的方法 |
| CN115260128B (zh) * | 2022-09-21 | 2022-12-09 | 苏州凯瑞医药科技有限公司 | 一种新型jak抑制剂关键中间体的制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001227755A1 (en) * | 2000-01-12 | 2001-07-24 | Merck And Co., Inc. | Inhibitors of prenyl-protein transferase |
| US7151096B2 (en) * | 2003-03-05 | 2006-12-19 | Irm Llc | Cyclic compounds and compositions as protein kinase inhibitors |
| JO2785B1 (en) | 2003-05-27 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinazoline derivatives |
| AU2004298448B2 (en) | 2003-12-18 | 2010-09-09 | Janssen Pharmaceutica N.V. | Pyrido- and pyrimidopyrimidine derivatives as anti- proliferative agents |
| EA200601176A1 (ru) | 2003-12-18 | 2006-10-27 | Янссен Фармацевтика Н.В. | 3-цианохинолиновые производные с антипролиферативной активностью |
| MY169441A (en) | 2004-12-08 | 2019-04-11 | Janssen Pharmaceutica Nv | 2,4, (4,6) pyrimidine derivatives |
| JO3088B1 (ar) | 2004-12-08 | 2017-03-15 | Janssen Pharmaceutica Nv | مشتقات كوينازولين كبيرة الحلقات و استعمالها بصفتها موانع كينيز متعددة الاهداف |
| UA92608C2 (en) * | 2005-06-30 | 2010-11-25 | Янссен Фармацевтика Н.В. | Cyclic anilino - pyridinotriazines as gsk-3 inhibitors |
| CN101360751B (zh) * | 2005-11-16 | 2011-09-14 | S*Bio私人有限公司 | 氧连接的嘧啶衍生物 |
| EP2170827B1 (fr) | 2007-06-21 | 2013-08-14 | Janssen Pharmaceutica, N.V. | Indolin-2-ones et aza-indolin-2-ones |
| AU2008281849B2 (en) | 2007-07-27 | 2013-11-28 | Janssen Pharmaceutica Nv | Pyrrolopyrimidines |
| WO2009112439A1 (fr) * | 2008-03-10 | 2009-09-17 | Janssen Pharmaceutica Nv | 4-aryl-2-anilino-pyrimidines comme inhibiteurs de plk kinases |
| BRPI0915105A2 (pt) | 2008-06-13 | 2019-09-24 | Novartis Ag | composto de 2,4'-biripidinila como inibidores da proteína cinase d úteis para o tratamento de ia insuficiência cardíaca e cancer |
-
2015
- 2015-04-01 MA MA039823A patent/MA39823A/fr unknown
- 2015-04-02 EA EA201692000A patent/EA029758B1/ru not_active IP Right Cessation
- 2015-04-02 MY MYPI2016001776A patent/MY185500A/en unknown
- 2015-04-02 UA UAA201611003A patent/UA118120C2/uk unknown
- 2015-04-02 WO PCT/EP2015/057401 patent/WO2015150557A1/fr not_active Ceased
- 2015-04-02 US US15/300,907 patent/US20170022201A1/en not_active Abandoned
- 2015-04-02 PE PE2016001843A patent/PE20161365A1/es active IP Right Grant
- 2015-04-02 MX MX2016012994A patent/MX369799B/es active IP Right Grant
- 2015-04-02 NZ NZ725406A patent/NZ725406A/en not_active IP Right Cessation
- 2015-04-02 AU AU2015239100A patent/AU2015239100B2/en not_active Ceased
- 2015-04-02 BR BR112016022700-0A patent/BR112016022700B1/pt not_active IP Right Cessation
- 2015-04-02 CA CA2942751A patent/CA2942751C/fr active Active
- 2015-04-02 SG SG11201608241UA patent/SG11201608241UA/en unknown
- 2015-04-02 ES ES15713523.7T patent/ES2665797T3/es active Active
- 2015-04-02 KR KR1020167028761A patent/KR102390274B1/ko not_active Expired - Fee Related
- 2015-04-02 JP JP2016560816A patent/JP6420362B2/ja active Active
- 2015-04-02 EP EP15713523.7A patent/EP3126365B1/fr active Active
- 2015-04-02 CN CN201580018081.0A patent/CN106132964B/zh active Active
-
2016
- 2016-09-25 IL IL248001A patent/IL248001B/en active IP Right Grant
- 2016-09-30 CL CL2016002495A patent/CL2016002495A1/es unknown
- 2016-09-30 ZA ZA2016/06768A patent/ZA201606768B/en unknown
- 2016-10-03 PH PH12016501962A patent/PH12016501962A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20160140739A (ko) | 2016-12-07 |
| CA2942751A1 (fr) | 2015-10-08 |
| SG11201608241UA (en) | 2016-10-28 |
| AU2015239100A1 (en) | 2016-09-29 |
| ES2665797T3 (es) | 2018-04-27 |
| CN106132964B (zh) | 2019-07-19 |
| JP6420362B2 (ja) | 2018-11-07 |
| IL248001B (en) | 2018-11-29 |
| ZA201606768B (en) | 2018-11-28 |
| UA118120C2 (uk) | 2018-11-26 |
| CL2016002495A1 (es) | 2017-02-24 |
| EA201692000A1 (ru) | 2017-01-30 |
| EP3126365A1 (fr) | 2017-02-08 |
| EA029758B1 (ru) | 2018-05-31 |
| CA2942751C (fr) | 2023-03-21 |
| PH12016501962B1 (en) | 2017-01-09 |
| WO2015150557A1 (fr) | 2015-10-08 |
| US20170022201A1 (en) | 2017-01-26 |
| BR112016022700B1 (pt) | 2022-01-11 |
| NZ725406A (en) | 2022-08-26 |
| JP2017509685A (ja) | 2017-04-06 |
| MX369799B (es) | 2019-11-21 |
| MY185500A (en) | 2021-05-19 |
| CN106132964A (zh) | 2016-11-16 |
| PE20161365A1 (es) | 2016-12-17 |
| MX2016012994A (es) | 2016-12-07 |
| KR102390274B1 (ko) | 2022-04-22 |
| KR102390274B9 (ko) | 2023-03-03 |
| BR112016022700A2 (fr) | 2017-08-15 |
| PH12016501962A1 (en) | 2017-01-09 |
| AU2015239100B2 (en) | 2019-06-27 |
| EP3126365B1 (fr) | 2018-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102390274B9 (ko) | 마크로사이클릭 피리딘 유도체 | |
| CL2016002461A1 (es) | Derivados macrocíclicos de pirimidina | |
| DK3319956T3 (da) | Substituerede oxopyridinderivater | |
| EP3319969A4 (fr) | Polymorphe de macrocycle de diaryle | |
| LT3204359T (lt) | Tetrahidroizochinolino dariniai | |
| MA54254A (fr) | Dérivés de benzodiazépine cytotoxique | |
| EP3457851A4 (fr) | Dérivés de sobétirome | |
| DK3168219T3 (da) | Pyridonderivat med tetrahydropyranylmethylgruppe | |
| DK3148591T3 (da) | Nanopartikel-lægemiddelkonjugater | |
| HUE048321T2 (hu) | Karabazol származékok | |
| DK3231803T3 (da) | Dihydroindolizinonderivat | |
| LT3371168T (lt) | Indolin-2-ono dariniai | |
| MA41790A (fr) | Dérivé de morphinane | |
| PT3131898T (pt) | Derivados de fluoroalquilfluoreno | |
| HRP20180826T1 (hr) | Klizni ležajevi za konstrukcije | |
| EP3309163A4 (fr) | Dérivé de dihydropyrrolopyrazole substitué | |
| EP3554637A4 (fr) | Dérivés de spiropipéridine | |
| MA49708A (fr) | Dérivés de dihétérocycle liés à cycloalkyle | |
| LT3097076T (lt) | Nauji cip-eikozanoidų dariniai | |
| MA41641A (fr) | Dérivés de tétrahydropyranylbenzamide | |
| CL2015000871S1 (es) | Pieza de rodillo | |
| FR3025199B1 (fr) | Derives de n-aryl-2-amino-4-aryl-pyrimidines polyethers macrocycliques | |
| IL249210A0 (en) | A pyridine derivative | |
| IL248900A0 (en) | Pyrazine derivatives | |
| PT3228616T (pt) | Derivados de piridina |